- 192
- 67 155
CLD AASLD Journal
Приєднався 16 вер 2019
Clinical Liver Disease (CLD) is no longer accepting new submissions or publishing new content. The final issue can be found at cldlearning.com. On behalf of our dedicated team of CLD editors, editorial board members, and staff, we thank each of you - our readers and contributors - for your unwavering support of the journal over the past 13 years. All CLD papers will remain freely available through the CLD website and PubMed. For any questions about AASLD publications please contact aasld@aasld.org. For other AASLD publications please visit: www.aasld.org/journals.
Management of patients with CHB outside the guidelines
Authors: Shiha, Gamal; Soliman, Riham; Hassan, Ayman; Farahat, Ahmed; Salem, Ahmed; Taha, Amr; Sabry, Ramy; Geith, Ahmed; Elshawaf, Ahmed; Mikhail, Nabiel
Clinical Liver Disease 23(1):e0183, January-June 2024. | DOI: 10.1097/CLD.0000000000000183
cldlearning.com
Clinical Liver Disease 23(1):e0183, January-June 2024. | DOI: 10.1097/CLD.0000000000000183
cldlearning.com
Переглядів: 32
Відео
Drug-induced autoimmune-like hepatitis
Переглядів 516 місяців тому
Authors: García-Cortés, Miren; Pinazo-Bandera, Jose M.; Lucena, M. Isabel; Andrade, Raúl J. Clinical Liver Disease 23(1):e0172, January-June 2024. | DOI: 10.1097/CLD.0000000000000172 COI: Miren García-Cortés advises and received grants from Gilead Sciences S.L.U. She received grants from AbbVie. The remaining authors have no conflicts to report. cldlearning.com
The impending hepatology workforce shortage: Ethical considerations for closing the gap
Переглядів 106 місяців тому
Authors: Reddy, K. Gautham; Prochaska, Micah; Fix, Oren K. Clinical Liver Disease 23(1):e0197, January-June 2024. | DOI: 10.1097/CLD.0000000000000197 COI: K. Gautham Reddy consults for and received grants from CymaBay. He is on the speakers’ bureau for Mallinckrodt. He received grants from Gilead, Cour, Durect, and Pliant. The remaining authors have no conflicts to report. cldlearning.com
Brain death: Controversies and reappraisals
Переглядів 156 місяців тому
Authors: Lazaridis, Christos Clinical Liver Disease 23(1):e0168, January-June 2024. | DOI: 10.1097/CLD.0000000000000168 COI: The author has no conflicts to report. cldlearning.com
Deciphering an expanding array of clinical and research frailty measures
Переглядів 66 місяців тому
Authors: Thuluvath, Avesh J.; Verna, Elizabeth C. Clinical Liver Disease 23(1):e0180, January-June 2024. | DOI: 10.1097/CLD.0000000000000180 COI: Elizabeth C. Verna received grants from Salix. The remaining author has no conflicts to report. cldlearning.com
Getting your transplant center ready for prime time: Health care system obstacles to prehabilitation
Переглядів 166 місяців тому
Authors: Earasi, Athidi; Kappus, Matthew Citation: Clinical Liver Disease 23(1):e0170, January-June 2024. | DOI: 10.1097/CLD.0000000000000170 COI: The authors have no conflicts to report. cldlearning.com
Cost-effectiveness analysis: The missing factor in the management of HCC
Переглядів 1386 місяців тому
Authors: Njei, Basile; Yi, Irvin; Strazzabosco, Mario Clinical Liver Disease 23(1):e0178, January-June 2024. | DOI: 10.1097/CLD.0000000000000178 COI: Mario Strazzabosco consults for Engitix. The remaining authors have no conflicts to report. cldlearning.com
Impact of alcohol use on liver disease outcomes
Переглядів 176 місяців тому
Authors: Desalegn, Hailemichael; Diaz, Luis Antonio; Rehm, Jürgen; Arab, Juan Pablo Less Clinical Liver Disease 23(1):e0192, January-June 2024. | DOI: 10.1097/CLD.0000000000000192 cldlearning.com
Management of depression/anxiety in patients with chronic liver disease
Переглядів 486 місяців тому
Authors: Garcia-Altieri, Mauro; Carrera-Mejias, Keila; Hernaez, Ruben Clinical Liver Disease 23(1):e0179, January-June 2024. | DOI: 10.1097/CLD.0000000000000179 cldlearning.com
HBV eradication from the host: Current understanding and challenges
Переглядів 496 місяців тому
Authors: Mbelle, Mzamo; Dusheiko, Geoffrey Clinical Liver Disease 23(1):e0188, January-June 2024. | DOI: 10.1097/CLD.0000000000000188 COI: Geoffrey Dusheiko is on the DSMB for Aligos Therapeutics, Janssen, Glaxo Smith Kline, Arbutus, Myr GMBH/Gilead Sciences, and Vir. He advises Antios, Gilead Sciences, and Precision Biosciences. He advises National Medical Research Council Singapore and World ...
Immune-mediated liver injury from checkpoint inhibitors: Best practices in 2024
Переглядів 1036 місяців тому
Authors: Swanson, Linnea A.; Hawa, Fadi; Fontana, Robert J. Clinical Liver Disease 23(1):e0191, January-June 2024. | DOI: 10.1097/CLD.0000000000000191 COI: Robert J. Fontana has received research support from Takeda Pharmaceuticals and Kezar Pharmaceuticals. Linnea A. Swanson and Fadi Hawa have no conflicts. cldlearning.com
Management of HBV reactivation: Challenges and opportunities
Переглядів 337 місяців тому
Authors: Mezzacappa, Catherine; Lim, Joseph K. Clinical Liver Disease 23(1):e0143, January-June 2024. | DOI: 10.1097/CLD.0000000000000143 COI: Joseph K. Lim received institutional grants from Gilead, Intercept, Inventiva, Novo Nordisk, Pfizer, and Viking. The remaining author has no conflicts to report. cldlearning.com
Finite therapy of chronic hepatitis B infection: Cons
Переглядів 327 місяців тому
Author: Hsu, Yao-Chun Clinical Liver Disease 23(1):e0146, January-June 2024. | DOI: 10.1097/CLD.0000000000000146 COI: Yao-Chun Hsu advises, is on the speakers’ bureau for, and received grants from Gilead. He advises Sysmex. He is on the speakers’ bureau for AbbVie, Bristol-Myers Squibb, Merck Sharp and Dohme, and Novartis. Earn CME for this article: cme.lww.com/browse/sources/222
HBV elimination in Africa-Current status and challenges
Переглядів 427 місяців тому
Authors: Sonderup, Mark W.; Spearman, C. Wendy Clinical Liver Disease 23(1):e0166, January-June 2024. | DOI: 10.1097/CLD.0000000000000166 COI: Mark W. Sonderup is on the speakers’ bureau for and received grants from Gilead. He is on the speakers’ bureau for Echosens. C. Wendy Spearman is on the speakers’ bureau and received grants from Gilead. She is on the speakers’ bureau for Abbott. cldlearn...
Role of artificial intelligence in the management of chronic hepatitis B infection
Переглядів 757 місяців тому
Authors: Su, Tung-Hung, Kao, Jia-Horng Clinical Liver Disease 23(1):e0164, January-June 2024. | DOI: 10.1097/CLD.0000000000000164 COI: Tun-Hung Su is on the speakers’ bureau for, consults for, and received grants from Gilead Sciences. He is on the speakers’ bureau for Abbott, Abbvie, Bristol-Myers Squibb, Merck Sharp and Dohme, Roche, and Sysmex. Jia-Horng Kao consults for and is on the speaker...
How to achieve a functional cure for chronic hepatitis B infection
Переглядів 7767 місяців тому
How to achieve a functional cure for chronic hepatitis B infection
Granulomatous hepatitis: Is it bugs, drugs, or other untoward culprits?
Переглядів 1537 місяців тому
Granulomatous hepatitis: Is it bugs, drugs, or other untoward culprits?
HDV: Epidemiology, lifecycle, testing, and treatment
Переглядів 537 місяців тому
HDV: Epidemiology, lifecycle, testing, and treatment
Impact of metabolic disorders on chronic hepatitis B
Переглядів 1207 місяців тому
Impact of metabolic disorders on chronic hepatitis B
Endo-bariatric therapies as a treatment strategy for MASLD
Переглядів 1108 місяців тому
Endo-bariatric therapies as a treatment strategy for MASLD
Inpatient management of fluid overload (ascites, hepatic hydrothorax, and anasarca)
Переглядів 1498 місяців тому
Inpatient management of fluid overload (ascites, hepatic hydrothorax, and anasarca)
Hep C screening and treatment during pregnancy in pregnant women in Egypt, Pakistan, and Ukraine
Переглядів 278 місяців тому
Hep C screening and treatment during pregnancy in pregnant women in Egypt, Pakistan, and Ukraine
The hepatitis C care cascade in CA state prisons
Переглядів 268 місяців тому
The hepatitis C care cascade in CA state prisons
The impact of alcohol on patients after bariatric surgery
Переглядів 178 місяців тому
The impact of alcohol on patients after bariatric surgery
The delta in management of HDV/HBV coinfection: Lessons from a case
Переглядів 128 місяців тому
The delta in management of HDV/HBV coinfection: Lessons from a case
EPP related liver disease: A patient friendly summary of the 23 evidence-based consensus guidelines
Переглядів 318 місяців тому
EPP related liver disease: A patient friendly summary of the 23 evidence-based consensus guidelines
HBV “Viral Elimination” in the Asia-Pacific region: Current status and challenges
Переглядів 119 місяців тому
HBV “Viral Elimination” in the Asia-Pacific region: Current status and challenges
Contraception in patients with liver disease and liver transplant
Переглядів 629 місяців тому
Contraception in patients with liver disease and liver transplant
Could the answer to NAFLD be hidden in diabetic therapy? The impact of T2DM treatment on NAFLD
Переглядів 4310 місяців тому
Could the answer to NAFLD be hidden in diabetic therapy? The impact of T2DM treatment on NAFLD
Important Announcement: AASLD Sunsetting of Clinical Liver Disease
Переглядів 7110 місяців тому
Important Announcement: AASLD Sunsetting of Clinical Liver Disease